申请人:Hoechst Aktiengesellschaft
公开号:US04216216A1
公开(公告)日:1980-08-05
Compounds of general formula ##STR1## are disclosed wherein appropriate substituents for R.sup.1, R.sup.2 to R.sup.5, R.sup.6, A, Q, X, and Z are defined for these novel hexahydropyrimidines. Procedures for the preparation of these compounds are also given. Because of the highly effective serotonin antagonistic activity in combination with a strong inhibiting effect on thrombocyte aggregation and good compatibility these compounds are effective in treating migraine. Additionally, the compounds also exhibit an anti-histamine activity, cause an increase in erythrocyte fluidity, a psychotropic activity, a weak bradykinin antagonism and hypotensive effects.
揭示了通式为##STR1##的化合物,其中为这些新型六氢嘧啶定义了适当的R.sup.1,R.sup.2至R.sup.5,R.sup.6,A,Q,X和Z的取代基。还给出了制备这些化合物的方法。由于高度有效的5-羟色胺拮抗活性,结合了强烈的抑制血小板聚集和良好的相容性,这些化合物对治疗偏头痛非常有效。此外,这些化合物还表现出抗组胺活性,引起红细胞流动性的增加,具有精神活性,弱的缓激肽拮抗作用和降压作用。